Abstract
Objective: The six-helix bundle (6-HB) is critical for HIV-1 membrane fusion. To disrupt this process, peptide inhibitors have been meticulously designed to target interactions within the 6-HB regions, thereby blocking membrane fusion and exerting inhibitory effects. Current peptide inhibitors like Enfuvirtide suffer from drug resistance and short in vivo half-life. This study aims to design novel anti-HIV-1 peptides by integrating heptad-repeat rules and membrane-anchor strategies. Methods: Artificial peptides were designed using HR rules from the HIV-1 gp41 6-HB motif and membrane-anchor modifications. Results: EK35S-Palm has emerged as a highly promising candidate for HIV-1 inhibition, exhibiting robust binding affinity to the target and effectively impeding the 6-HB spontaneous formation. Discussion: HR-based design avoids viral sequence homology, and membrane anchoring enhances local agent concentration, improving pharmacokinetics. The HR binding and membrane stabilization of EK35S-Palm provide synergistic inhibition. Conclusions: Integrating HR structural design with membrane-anchor strategies yields potent HIV-1 fusion inhibitors. EK35S-Palm demonstrates superior efficacy and stability over current therapies. These approaches hold great potential for overcoming the current therapy limitations and advancing the more effective and durable HIV-1 fusion inhibitors.
Funding Information
  • Science and Technology Project of Inner Mongolia Autonomous Region of China (2025KJHZ0064)
  • State Key Laboratory of Natural and Biomimetic Drugs (KF2025034)
  • Sub-project of Quality Enhancement and Cultivation Discipline for the Pharmacy College of Inner Mongolia Medical University (YXY2024TZ701)
  • Scientific Staring Foundation for Ph.D. Research of Inner Mongolia Medical University (YKD2025BSQD023)
  • “Cultivation of Excellence” Project for Science and Technology Innovation of Inner Mongolia Medical University (YCPY2025005)
  • Undergraduate innovation and entrepreneurship training program of Inner Mongolia Medical University (101322025011)
  • Undergraduate innovation and entrepreneurship training program of Inner Mongolia Medical University (101322025051)
  • Basic and Applied Basic Research Science and Technology Program Projects of Hohhot (2024-GUI-JI-20)

This publication has 21 references indexed in Scilit: